These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11675291)

  • 1. [Clinical significance of Epstein-Barr virus load].
    Dehée A
    Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():28-33. PubMed ID: 11675291
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
    Green M; Webber SA
    Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
    Martin SI; Zukerberg L; Robbins GK
    Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
    Petrovic LM
    Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus and posttransplant lymphoproliferative disease.
    Holmes R
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular diagnosis of Epstein-Barr virus.
    Häusler M; Scheithauer S; Ritter K; Kleines M
    Expert Rev Mol Diagn; 2003 Jan; 3(1):81-92. PubMed ID: 12528366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort.
    Baiocchi OC; Colleoni GW; Caballero OL; Vettore AL; Andrade AL; Pestana JO
    Haematologica; 2004 Mar; 89(3):366-8. PubMed ID: 15020282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics of two real-time PCR assays for the quantification of Epstein-Barr virus DNA.
    Hill CE; Harris SB; Culler EE; Zimring JC; Nolte FS; Caliendo AM
    Am J Clin Pathol; 2006 May; 125(5):665-71. PubMed ID: 16707366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) early-antigen antibodies and EBV DNA load in blood, in posttransplantation lymphoproliferative disease.
    Leruez-Ville M; Talbotec C; Iserin F; Salomon R; Lacaille F; Rouzioux C
    J Infect Dis; 2004 Oct; 190(8):1524-5; author reply 1525-6. PubMed ID: 15378447
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical usefulness of Epstein-Barr viral load in solid-organ transplantation.
    Buteau C; Paya CV
    Liver Transpl; 2001 Feb; 7(2):157-9. PubMed ID: 11172403
    [No Abstract]   [Full Text] [Related]  

  • 15. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation.
    Sirvent N; Reviron D; de Lamballerie X; Michel G
    Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T; Ohkohchi N; Satomi S; Hoshino Y; Kimura H
    Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor or recipient origin of posttransplantation lymphoproliferative disorders: the traces of the Epstein-Barr virus.
    Volk HD; Babel N; Reinke P
    Transplantation; 2001 Aug; 72(3):361-2. PubMed ID: 11502960
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.